Loading...
Indian Pharmaceutical Exporter · #10 for Amlodipine · $5.7M export value · DGFT Verified
Medreich Limited is the #10 Indian exporter of Amlodipine with $5.7M in export value and 113 verified shipments. Medreich Limited holds a 0.0% market share in Amlodipine exports across 4 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
| 1 |
| 0.1% |
Medreich Limited exports Amlodipine to 5 countries. The largest destination is JAPAN accounting for 92.7% of Medreich Limited's Amlodipine shipments, followed by SPAIN (5.2%) and PORTUGAL (1.8%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MEIJI SEIKA PHARMATECH CO., LTD | JAPAN | $2.4M | 49 |
| MEIJI SEIKA PHARMA CO LIMITED | JAPAN | $701.2K | 17 |
| MEIJI SEIKA PHARMATECH CO. LIMITED | JAPAN | $405.4K | 9 |
| MEIJI SEIKA PHARMA CO., LTD. | JAPAN | $300.0K | 6 |
| MEIJI SEIKA PHARMA CO.LTD, ODAWARA | JAPAN | $250.0K | 5 |
| MEIJI SEIKA PHARMA CO LTD ODAWARA | JAPAN | $250.0K | 5 |
| MABO FARMA S.A | SPAIN | $165.1K | 10 |
| MEIJI SEIKA PHARMA CO LTD | JAPAN | $150.0K | 3 |
| FHC FARMACEUTICA LDA | PORTUGAL | $86.7K | 2 |
| MABO FARMA S A | SPAIN | $50.8K | 2 |
Medreich Limited supplies Amlodipine to 19 buyers globally. The largest buyer is MEIJI SEIKA PHARMATECH CO., LTD (JAPAN), followed by MEIJI SEIKA PHARMA CO LIMITED (JAPAN) and MEIJI SEIKA PHARMATECH CO. LIMITED (JAPAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $311.2M worth of Amlodipine through 15,000 shipments from 599 suppliers to 159 countries, serving 1,862 buyers globally. Medreich Limited contributes $5.7M to this total, accounting for 0.0% of India's Amlodipine exports. Medreich Limited ships Amlodipine to 5 countries through 19 buyers.
Medreich Limited's average Amlodipine shipment value is $50.0K per consignment, based on 113 shipments totaling $5.7M. The largest destination is JAPAN (92.7% of Medreich Limited's Amlodipine exports).
Medreich Limited ranks #10 among 599 Indian Amlodipine exporters with a 0.0% market share. The top 3 exporters are CIPLA LIMITED ($101.8M), ALKEM LABORATORIES LIMITED ($37.3M), UNICHEM LABORATORIES LIMITED ($34.5M). Medreich Limited processed 113 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMLODIPINE BESILATE ORALLY DISINTEGRATIN | $900.0K | 18 |
| AMLODIPINE BESILATE ORALLY DISINTEGRATING TABLETS JP 2 5MG PO NO MM 153 PACK SIZE 60000S QTY 210 682 | $100.0K | 2 |
| AMLODIPINE BESILATE ORALLY DISINTEGRATING TABLETS JP 2 5MG PO NO MM 154 PACK SIZE 60000S QTY 71 891 | $100.0K | 2 |
| AMLODIPINE 5 MG ORODISPERSABLE TABLETS | $78.2K | 4 |
| AMLODIPINE BESILATE ORALLY DISINTEGRATING TABLETS JP 10MG PO NO MM 125 APO010 PACK SIZE 25000S QTY 199 089 | $50.0K | 1 |
| AMLODIPINE BESILATE ORALLY DISINTEGRATING TABLETS JP 5MG, PO NO.MM-157, PACK SIZE:40000S, QTY:216.687 | $50.0K | 1 |
| AMLODIPINE BESILATE ORALLY DISINTEGRATING TABLETS JP 2.5MG, PO NO.MM-157, PACK SIZE:60000S, QTY:143.084 | $50.0K | 1 |
| AMLODIPINE BESILATE ORALLY DISINTEGRATING TABLETS JP 2.5MG, PO NO.MM-156, PACK SIZE:60000S, QTY:68.938 | $50.0K | 1 |
| AMLODIPINE BESILATE ORALLY DISINTEGRATING TABLETS JP 5MG PO NO.MM-158 - 22.12.2022 PACK SIZE:40000S QTY:70 | $50.0K | 1 |
| AMLODIPINE BESILATE ORALLY DISINTEGRATING TABLETS JP 5MG PO NO.MM-157 PACK SIZE:40000S QTY:140.404 | $50.0K | 1 |
Medreich Limited exports 109 distinct Amlodipine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMLODIPINE BESILATE ORALLY DISINTEGRATIN with 18 shipments worth $900.0K.
What Medreich Limited must comply with to export Amlodipine to its top destination countries
Approval Process
Generic Drug Application per Japan Pharmaceutical Affairs Act. Dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Timeline: 12–24 months
GMP & Export Requirements
Japanese GMP (J-GMP); PMDA on-site inspection of Indian manufacturing facility
Foreign Manufacturer Accreditation from PMDA; Japanese MAH (Marketing Authorization Holder) partner required
Note: Japan requires Yen-denominated NHI drug price listing. Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | EMCURE PHARMACEUTICALS LIMITED | $7.0M | 468 | 25 | $14.9K |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $6.8M | 135 | 6 | $50.0K |
| 10 | MEDREICH LIMITED ★ | $5.7M | 113 | 4 | $50.0K |
| 13 | ZYDUS LIFESCIENCES LIMITED | $5.6M | 263 | 20 | $21.1K |
| 14 | AUROBINDO PHARMA LTD | $4.1M | 183 | 8 | $22.7K |
Medreich Limited ranks #10 among 599 Indian Amlodipine exporters. Average shipment value of $50.0K compared to the market average of $519.5K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 2,082 | 13.9% |
| NHAVA SHEVA SEA (INNSA1) | 1,850 | 12.3% |
| JNPT/ NHAVA SHEVA SEA | 1,599 | 10.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,229 | 8.2% |
| DELHI AIR | 802 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 748 | 5.0% |
| JNPT | 710 | 4.7% |
| Bombay Air | 417 | 2.8% |
Medreich Limited also exports these cardiovascular products. Each links to the detailed product page.
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
Medreich Limited exports 42 products worth $224.8M. Beyond Amlodipine, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Amlodipine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 159+ countries, 1,862+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Amlodipine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amlodipine. For current shipment-level data, contact TransData Nexus.